Details for 2019782691

Up to date per 03.04.2026

Actions

Title / Product Name

3- (5-HYDROXY-1-OXOISOINDOLIN-2-YL) PIPERIDIN-2,6-DION-DERIVATE UND IHRE VERWENDUNG ZUR BEHANDLUNG VON ZINKFINGER- 2 (IKZF2) -ABHÄNGIGEN KRANKHEITEN

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019782691

EP Publication Number

3820573

E-Number

1596798

Language

PCT Number

IB19055804

Publication Date

19.05.2021 A

09.08.2023 B1

Registration Date

09.08.2023

AT Publication Date

15.08.2023

Application Date

08.07.2019

Registration Number

Priorities

10.07.2018

201862695920 P

18.04.2019

201962835543 P

IPC

A61P 35/00 20060101AFI20200117BHEP

Maximum Duration of Protection

08.07.2039

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

Schwarz & Partner Patentanwälte GmbHWipplingerstraße 301010 WienAT

Inventor

ADCOCK, ClaireNovartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US

BONAZZI, SimoneNovartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US

CERNIJENKO, ArtiomNovartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US

LAM, PhilipNovartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US

LINKENS, Kathryn TaylorNovartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US

MALIK, Hasnain AhmedNovartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US

THOMSEN, Noel Marie-FranceNovartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US

VISSER, Michael ScottNovartis Institutes for BioMedical Research, Inc. 250 Massachusetts Avenue Cambridge, Massachusetts 02139US

Information about Fees